Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

08:24 EDT 21st April 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 24,000+

Friday 18th April 2014

Work Comp Leader to Deliver Industry Insight on Prescription Drug Abuse at National Rx Drug Abuse Summit

The merged entity of Progressive Medical and PMSI, a workers’ compensation specialty services company, will share insight on the issue of prescription drug abuse in the workers’ compensation system at the National Rx Drug Abuse Summit, April 22-24, 2014, in Atlanta. Memphis, TN (PRWEB) April 18, 2014 The merged entity of Progressive Medical and PMSI, a workers’ compensation specialty servic...

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi

NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment of hepatitis C, US biotech firm Gilead Sciences’ Sovaldi (sofosbuvir).

Phase 1/2 Results Positive for Cancer Drug

XBiotech is announcing that results from its Phase 1/2 oncology study conducted at MD Anderson Cancer Center in Houston, TX were published in Lancet Oncology. The featured article describes the outcome in 52 advanced cancer patients treated with Xilonix, XBiotech’s novel, non-cytotoxic, anti-tumor therapy. The so-called true human antibody therapy was reported to have an excellent safety profile...

First Asian approval for ophthalmic drug Jetrea, in Malaysia

Belgian biotech firm ThromboGenics NV revealed today that Jetrea (ocriplasmin) has been approved in Malaysia for the treatment of adults with vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to...

Ivabradine Fast Tracked for Chronic HF

The U.S. Food and Drug Administration (FDA) has granted fast track designation for investigational ivabradine for patients with chronic heart failure (HF).

Second Series of CASIS-Sponsored Research Payloads Launch to the International Space Station

KENNEDY SPACE CENTER, Fla., April 18, 2014 /PRNewswire-USNewswire/ -- The Center for the Advancement of Science in Space (CASIS) is proud to announce several sponsored research payloads have launched to the International Space Station (ISS) onboard the Space Exploration Technology Corporation's (SpaceX) Dragon cargo capsule. This marks the second series of investigations headed to the station...

Antibody Drug Conjugates: Technologies and Global Markets

WEST HARTFORD, Conn., April 18, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Antibody Drug Conjugates: Technologies and Global Markets" at GIIResearch.com The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1...

Free Dermatological Drug Samples Increase Prescription Costs

A new study has shown that free drug samples given to dermatologists can increase overall prescribing costs. Medscape Medical News

Ragwitek Approved for Adult Ragweed Allergy

FRIDAY, April 18, 2014 -- Ragwitek has been approved by the U.S. Food and Drug Administration to treat allergy to short ragweed among adults aged 18 to 65. The once-daily tablet contains an extract from short ragweed (Ambrosia artemisiifolia)...

Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer. The...

FDA briefing docs rebuff MoxDuo IR

FDA's Bob Rappaport said the agency's review team has been "unable to conclude that there is a safety benefit" for MoxDuo IR morphine/oxycodone from QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY), which is under review to treat moderate to severe acute pain....

NCI researchers: cancer treatments costly to compare

In an article published in the New England Journal of Medicine, researchers at NIH's National Cancer Institute made several proposals on how to fund comparative effectiveness trials for expensive new cancer drugs vs. cheaper drugs. The researchers no...

VA: doctors should defer HCV treatment for some

The U.S. Department of Veteran Affairs recommended regimens containing Sovaldi sofosbuvir from Gilead Sciences Inc. (NASDAQ:GILD) and Olysio simeprevir from Johnson & Johnson (NYSE:JNJ) for most HCV patients, but said it would be "reasonable" for doc...

Aspirin Tied to Fewer Deaths in COPD Flares

(MedPage Today) -- High platelet counts in chronic obstructive pulmonary disease exacerbations were linked to elevated mortality, which being on an antiplatelet drug appeared to counteract, an observational study showed.

WCRI to Present Research on Florida Ban on Physician Dispensing of Opioids at National Rx Drug Abuse Summit

Dr. Richard Victor, executive director of the Workers Compensation Research Institute (WCRI), will present findings from the Institute’s study, Impact of Banning Physician Dispensing of Opioids in Florida, at the 2014 National Rx Drug Abuse Summit. The session starts at 3 p.m. on Wednesday, April 23, 2014 in room A706. Cambridge, MA (PRWEB) April 18, 2014 Dr. Richard Victor, executive director...

Vyrix Files for $29M IPO to Develop Anti-Premature Ejaculation Drug

Vyrix Pharmaceuticals, a privately held Colorado-based drug development company attempting to develop a treatment for premature ejaculation, is going public and seeks to raise $28.75 million, according to SEC filings. The company did not announce a s...

Finding turns neuroanatomy on its head: Researchers present new view of myelin

Neuroscientists have made a discovery that turns 160 years of neuroanatomy on its head. Myelin, the electrical insulating material long known to be essential for the fast transmission of impulses along the axons of nerve cells, is not as ubiquitous a...

Pharmaceutical Digital Marketing: Transforming Your Multichannel Marketing Mix to Unlock Brand Value

WEST HARTFORD, Conn., April 18, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Pharmaceutical Digital Marketing: ransforming Your Mulichannel Marketing Mix to Unlock Brand Value" at GIIResearch.com As regulatory and logistical barriers lessen, eMarketing is growing more prevalent in the life sciences industry. The digital space unlocks...

Anti-Seizure Drug Could Reduce Alcohol Consumption

Researchers from Boston University School of Medicine (BUSM) have discovered that the anti-seizure drug ezogabine, reduced alcohol consumption in an experimental model.

Citizens Rx to Address "the Last Mile" of Specialty Drug Shipment

OAK PARK, Ill., April 18, 2014 /PRNewswire/ -- When it comes to shipping Specialty Medications, providers need to ensure that the "Last Mile isn't also the Longest," according to Bill Bailey, R.Ph, Chief Operations Officer of Citizens, Rx LLC. Mr. Bailey, one of the nation's foremost experts on Specialty and Mail order Operations, will be presenting "Specialty Pharmacy Shipping: Improving Your Br...

Cancer Research U.K. to launch 14-drug, personalized medicine trial

British researchers, working with two global pharmaceutical companies, are planning to launch a different kind of personalized medicine clinical trial that could change how cancer drugs are studied and potentially cut the time and cost of bringing th...

Multi-Target TB Drug May Treat Other Diseases, Evade Resistance

Read more about Multi-Target TB Drug May Treat Other Diseases, Evade Resistance

Multi-Target TB Drug Could Treat Other Diseases, Evade Resistance

A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a study by University of Illinois chemists and collaborators.  Led by U. of I. chemistry professor Eric Oldfield, the team determined

UnitedHealth Cites Health Law, Costly Hepatitis Drug In Reporting Lower Earnings

The health law's effect was mixed, officials said, because the company did not participate in many of the online marketplaces, but it did see more customers for its Medicaid plans. Officials are considering a bigger role in the marketplaces next year. The New York Times: Health Law Bellwether, UnitedHealth Posts Lower Profit The UnitedHealth Group, one of the nation's largest health insurers, repo...

Canada is First to Approve GSK's New COPD Drug

GlaxoSmithKline plc announced that Incruse Ellipta (umeclidinium, as umeclidinium bromide) has received market authorization in Canada for the long-term once-daily maintenance bronchodilator treatment of airfl


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement